 Matthew Jackman
Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Weight Gain | 15 | 2019 | 536 | 1.620 |
Why?
| | Energy Metabolism | 25 | 2024 | 926 | 1.400 |
Why?
| | Obesity | 23 | 2022 | 3007 | 1.300 |
Why?
| | Dietary Fats | 13 | 2018 | 303 | 1.300 |
Why?
| | Weight Loss | 11 | 2021 | 794 | 1.240 |
Why?
| | Adipocytes | 6 | 2025 | 220 | 0.930 |
Why?
| | Caloric Restriction | 4 | 2019 | 125 | 0.830 |
Why?
| | Adipose Tissue | 10 | 2022 | 645 | 0.640 |
Why?
| | Mitochondria, Muscle | 4 | 2019 | 120 | 0.600 |
Why?
| | Rats, Wistar | 12 | 2024 | 451 | 0.540 |
Why?
| | Physical Conditioning, Animal | 6 | 2025 | 246 | 0.540 |
Why?
| | Energy Intake | 13 | 2020 | 510 | 0.530 |
Why?
| | Diet, High-Fat | 9 | 2018 | 253 | 0.480 |
Why?
| | Diet, Fat-Restricted | 5 | 2013 | 77 | 0.470 |
Why?
| | Body Weight | 7 | 2024 | 992 | 0.460 |
Why?
| | Muscle, Skeletal | 13 | 2022 | 1747 | 0.440 |
Why?
| | Ovariectomy | 6 | 2025 | 158 | 0.420 |
Why?
| | Leptin | 3 | 2025 | 238 | 0.380 |
Why?
| | Diet, Reducing | 1 | 2011 | 90 | 0.340 |
Why?
| | Fatty Liver | 5 | 2018 | 237 | 0.330 |
Why?
| | Rats | 19 | 2024 | 5556 | 0.330 |
Why?
| | Lipid Metabolism | 7 | 2017 | 522 | 0.330 |
Why?
| | Liver | 9 | 2024 | 1821 | 0.310 |
Why?
| | Lactation | 3 | 2018 | 190 | 0.300 |
Why?
| | Animals | 38 | 2025 | 37328 | 0.280 |
Why?
| | Genes, Mitochondrial | 1 | 2008 | 13 | 0.280 |
Why?
| | NADH Dehydrogenase | 1 | 2008 | 20 | 0.280 |
Why?
| | Intra-Abdominal Fat | 1 | 2008 | 89 | 0.260 |
Why?
| | Triglycerides | 6 | 2015 | 510 | 0.260 |
Why?
| | Fatty Acids | 4 | 2021 | 446 | 0.260 |
Why?
| | Physical Exertion | 3 | 2011 | 208 | 0.250 |
Why?
| | Estradiol | 2 | 2024 | 523 | 0.250 |
Why?
| | Antibodies, Blocking | 1 | 2025 | 36 | 0.240 |
Why?
| | Antigens, Protozoan | 1 | 2025 | 32 | 0.240 |
Why?
| | Antibodies, Protozoan | 1 | 2025 | 41 | 0.230 |
Why?
| | Plasmodium falciparum | 1 | 2025 | 34 | 0.230 |
Why?
| | Malaria, Falciparum | 1 | 2025 | 31 | 0.230 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2025 | 42 | 0.230 |
Why?
| | Ovary | 3 | 2024 | 225 | 0.230 |
Why?
| | Menopause | 3 | 2019 | 317 | 0.230 |
Why?
| | Lipoprotein Lipase | 2 | 2021 | 56 | 0.230 |
Why?
| | Overweight | 2 | 2022 | 589 | 0.230 |
Why?
| | Protozoan Proteins | 1 | 2025 | 88 | 0.230 |
Why?
| | Polymorphism, Genetic | 1 | 2008 | 619 | 0.220 |
Why?
| | Hematopoietic Stem Cells | 2 | 2025 | 408 | 0.220 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2025 | 123 | 0.220 |
Why?
| | Milk | 3 | 2018 | 122 | 0.220 |
Why?
| | Insulin Resistance | 3 | 2025 | 1221 | 0.220 |
Why?
| | Subcutaneous Fat | 2 | 2015 | 81 | 0.220 |
Why?
| | Oxidative Phosphorylation | 3 | 2016 | 204 | 0.210 |
Why?
| | Adaptation, Physiological | 4 | 2015 | 561 | 0.210 |
Why?
| | Body Composition | 5 | 2024 | 704 | 0.200 |
Why?
| | Antibodies, Neutralizing | 1 | 2025 | 321 | 0.190 |
Why?
| | Fructokinases | 2 | 2013 | 35 | 0.190 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 247 | 0.190 |
Why?
| | Oxidation-Reduction | 6 | 2011 | 1080 | 0.180 |
Why?
| | Oxygen Consumption | 4 | 2019 | 712 | 0.180 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2014 | 32 | 0.180 |
Why?
| | Antibodies, Viral | 1 | 2025 | 654 | 0.180 |
Why?
| | Exercise | 4 | 2018 | 2113 | 0.170 |
Why?
| | Mitochondria | 5 | 2022 | 962 | 0.170 |
Why?
| | Motor Activity | 2 | 2019 | 717 | 0.160 |
Why?
| | alpha-Linolenic Acid | 1 | 2000 | 8 | 0.160 |
Why?
| | Stearic Acids | 1 | 2000 | 16 | 0.160 |
Why?
| | Homeostasis | 3 | 2015 | 632 | 0.160 |
Why?
| | Oleic Acid | 1 | 2000 | 42 | 0.160 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 656 | 0.160 |
Why?
| | Appetite | 1 | 2020 | 71 | 0.160 |
Why?
| | Muscle Fibers, Fast-Twitch | 2 | 2016 | 17 | 0.150 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 213 | 0.150 |
Why?
| | Muscle Fibers, Slow-Twitch | 2 | 2016 | 23 | 0.150 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 16 | 0.150 |
Why?
| | Fasting | 2 | 2000 | 283 | 0.150 |
Why?
| | Lipogenesis | 1 | 2019 | 64 | 0.150 |
Why?
| | Thermogenesis | 1 | 2019 | 46 | 0.150 |
Why?
| | Antibodies, Monoclonal | 1 | 2025 | 1456 | 0.140 |
Why?
| | Mitochondria, Liver | 2 | 2013 | 70 | 0.140 |
Why?
| | Physical Endurance | 2 | 2016 | 276 | 0.140 |
Why?
| | Diet | 3 | 2018 | 1277 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 60 | 0.140 |
Why?
| | Global Health | 1 | 2021 | 384 | 0.130 |
Why?
| | Cold Temperature | 1 | 2019 | 196 | 0.130 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2017 | 48 | 0.130 |
Why?
| | Cholesterol | 1 | 2019 | 404 | 0.130 |
Why?
| | Eating | 1 | 2020 | 393 | 0.130 |
Why?
| | Adipogenesis | 1 | 2017 | 56 | 0.130 |
Why?
| | Mice | 13 | 2025 | 17969 | 0.130 |
Why?
| | Sphingolipids | 1 | 2018 | 80 | 0.130 |
Why?
| | Postprandial Period | 2 | 2015 | 111 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 4 | 2010 | 2511 | 0.130 |
Why?
| | Recurrence | 4 | 2019 | 1108 | 0.130 |
Why?
| | Metabolic Diseases | 1 | 2018 | 114 | 0.130 |
Why?
| | Catecholamines | 1 | 1996 | 89 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2017 | 142 | 0.120 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 180 | 0.120 |
Why?
| | Caffeine | 1 | 1996 | 72 | 0.120 |
Why?
| | Female | 24 | 2025 | 75814 | 0.120 |
Why?
| | Bone Density | 1 | 2019 | 496 | 0.120 |
Why?
| | Mental Health Services | 1 | 2021 | 445 | 0.120 |
Why?
| | Lipectomy | 1 | 2015 | 8 | 0.120 |
Why?
| | Carbon Radioisotopes | 3 | 2006 | 29 | 0.110 |
Why?
| | Thigh | 1 | 2015 | 49 | 0.110 |
Why?
| | Insulin | 3 | 2022 | 2472 | 0.110 |
Why?
| | Central Nervous System Stimulants | 1 | 1996 | 178 | 0.110 |
Why?
| | Male | 21 | 2021 | 70140 | 0.110 |
Why?
| | Cryoelectron Microscopy | 2 | 2025 | 193 | 0.110 |
Why?
| | Hyperlipidemias | 1 | 2015 | 126 | 0.110 |
Why?
| | Breast Feeding | 1 | 2018 | 441 | 0.110 |
Why?
| | Glycogen | 2 | 2008 | 54 | 0.100 |
Why?
| | Time Factors | 4 | 2019 | 6951 | 0.100 |
Why?
| | Transcription Factors | 3 | 2019 | 1706 | 0.100 |
Why?
| | Sucrose | 1 | 2013 | 111 | 0.100 |
Why?
| | Disease Models, Animal | 6 | 2019 | 4414 | 0.100 |
Why?
| | Physical Fitness | 1 | 2014 | 207 | 0.100 |
Why?
| | Hormones | 2 | 2010 | 138 | 0.100 |
Why?
| | Exercise Tolerance | 1 | 2014 | 281 | 0.090 |
Why?
| | Mothers | 2 | 2018 | 776 | 0.090 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 5866 | 0.090 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2011 | 33 | 0.090 |
Why?
| | Appetite Regulation | 1 | 2011 | 32 | 0.090 |
Why?
| | Glucose Transporter Type 1 | 1 | 2011 | 48 | 0.090 |
Why?
| | Estrous Cycle | 1 | 2010 | 19 | 0.080 |
Why?
| | Blood Glucose | 2 | 2018 | 2286 | 0.080 |
Why?
| | Metabolism | 1 | 2010 | 43 | 0.080 |
Why?
| | Citric Acid Cycle | 2 | 2003 | 58 | 0.080 |
Why?
| | Models, Biological | 2 | 2016 | 1810 | 0.080 |
Why?
| | Biopsy | 2 | 2018 | 1073 | 0.080 |
Why?
| | Membrane Proteins | 2 | 2013 | 1144 | 0.080 |
Why?
| | Neural Pathways | 1 | 2011 | 302 | 0.080 |
Why?
| | Dietary Carbohydrates | 2 | 2009 | 151 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2017 | 2502 | 0.070 |
Why?
| | Sex Characteristics | 3 | 2018 | 783 | 0.070 |
Why?
| | Estrogen Receptor alpha | 1 | 2009 | 145 | 0.070 |
Why?
| | Adiponectin | 2 | 2022 | 243 | 0.070 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 352 | 0.070 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2008 | 20 | 0.070 |
Why?
| | Humans | 15 | 2025 | 141284 | 0.070 |
Why?
| | Basal Metabolism | 1 | 2008 | 63 | 0.070 |
Why?
| | Adiposity | 4 | 2015 | 520 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 174 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 183 | 0.060 |
Why?
| | Carbon Dioxide | 2 | 2006 | 241 | 0.060 |
Why?
| | Estrogens | 1 | 2009 | 371 | 0.060 |
Why?
| | Palmitates | 1 | 2006 | 21 | 0.060 |
Why?
| | Breeding | 1 | 2006 | 65 | 0.060 |
Why?
| | Pyruvic Acid | 2 | 2003 | 55 | 0.060 |
Why?
| | Intestinal Absorption | 1 | 2006 | 92 | 0.060 |
Why?
| | Malaria Vaccines | 1 | 2025 | 10 | 0.060 |
Why?
| | Cross Reactions | 1 | 2025 | 132 | 0.060 |
Why?
| | Down-Regulation | 1 | 2008 | 636 | 0.060 |
Why?
| | Photoperiod | 2 | 2019 | 53 | 0.060 |
Why?
| | Adult | 8 | 2022 | 39319 | 0.050 |
Why?
| | Enteral Nutrition | 1 | 2006 | 208 | 0.050 |
Why?
| | Rabbits | 2 | 1996 | 664 | 0.050 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 42 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 262 | 0.050 |
Why?
| | Epitopes | 1 | 2025 | 476 | 0.050 |
Why?
| | Phosphorylation | 1 | 2008 | 1753 | 0.050 |
Why?
| | Perilipin-2 | 2 | 2013 | 41 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2025 | 490 | 0.050 |
Why?
| | Mice, Inbred BALB C | 1 | 2025 | 1261 | 0.050 |
Why?
| | Animals, Newborn | 2 | 2017 | 866 | 0.050 |
Why?
| | Fructose | 2 | 2013 | 117 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.050 |
Why?
| | Pregnancy | 4 | 2018 | 7035 | 0.050 |
Why?
| | Indians, North American | 1 | 2008 | 655 | 0.050 |
Why?
| | In Vitro Techniques | 3 | 2003 | 1059 | 0.040 |
Why?
| | Calorimetry, Indirect | 2 | 2011 | 85 | 0.040 |
Why?
| | Digestive System | 1 | 2000 | 28 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2019 | 2815 | 0.040 |
Why?
| | Exercise Test | 2 | 2009 | 620 | 0.040 |
Why?
| | Betaine | 2 | 2013 | 65 | 0.040 |
Why?
| | Feeding Behavior | 2 | 2018 | 679 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 17 | 0.040 |
Why?
| | Protein Binding | 1 | 2025 | 2233 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 34 | 0.040 |
Why?
| | Adipose Tissue, Brown | 1 | 2019 | 56 | 0.040 |
Why?
| | Fever | 1 | 2000 | 310 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 269 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 444 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 156 | 0.040 |
Why?
| | Perilipin-1 | 1 | 2017 | 17 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 38 | 0.030 |
Why?
| | Models, Animal | 1 | 2019 | 391 | 0.030 |
Why?
| | Phenotype | 1 | 2006 | 3172 | 0.030 |
Why?
| | Adenosine Triphosphate | 2 | 2016 | 484 | 0.030 |
Why?
| | Cell Size | 1 | 2017 | 88 | 0.030 |
Why?
| | Transcriptome | 1 | 2024 | 1007 | 0.030 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 71 | 0.030 |
Why?
| | Glucose Clamp Technique | 1 | 2018 | 197 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 225 | 0.030 |
Why?
| | Cohort Studies | 1 | 2008 | 5809 | 0.030 |
Why?
| | Nutritional Status | 1 | 2000 | 357 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2009 | 2246 | 0.030 |
Why?
| | Temperature | 1 | 2000 | 668 | 0.030 |
Why?
| | Running | 1 | 2019 | 229 | 0.030 |
Why?
| | PPAR gamma | 1 | 2017 | 175 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 367 | 0.030 |
Why?
| | Phosphocreatine | 1 | 2016 | 44 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2011 | 11216 | 0.030 |
Why?
| | Creatine Kinase | 1 | 2016 | 72 | 0.030 |
Why?
| | Physical Conditioning, Human | 1 | 2016 | 40 | 0.030 |
Why?
| | Norepinephrine | 1 | 1996 | 190 | 0.030 |
Why?
| | Electron Transport | 1 | 1996 | 116 | 0.030 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2015 | 14 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2013 | 3042 | 0.030 |
Why?
| | Ethanol | 1 | 2000 | 627 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1327 | 0.030 |
Why?
| | Lactic Acid | 1 | 1996 | 303 | 0.030 |
Why?
| | Double-Blind Method | 2 | 1996 | 1992 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 332 | 0.030 |
Why?
| | Bicycling | 1 | 1995 | 118 | 0.030 |
Why?
| | Choline | 1 | 1995 | 131 | 0.030 |
Why?
| | Proteins | 2 | 2013 | 1007 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 40 | 0.030 |
Why?
| | Body Temperature | 1 | 1994 | 224 | 0.030 |
Why?
| | Cell Respiration | 1 | 2013 | 106 | 0.030 |
Why?
| | Middle Aged | 4 | 2018 | 34658 | 0.030 |
Why?
| | Mammary Glands, Animal | 1 | 2014 | 127 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1994 | 550 | 0.020 |
Why?
| | Meals | 1 | 2014 | 132 | 0.020 |
Why?
| | Circadian Rhythm | 2 | 2009 | 509 | 0.020 |
Why?
| | Fatigue | 1 | 1995 | 342 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1244 | 0.020 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2014 | 195 | 0.020 |
Why?
| | DNA Methylation | 1 | 2017 | 643 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2014 | 351 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2055 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1483 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 296 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 308 | 0.020 |
Why?
| | Calcium | 1 | 2016 | 1175 | 0.020 |
Why?
| | Methylnitrosourea | 1 | 2009 | 7 | 0.020 |
Why?
| | Thermodynamics | 2 | 2003 | 423 | 0.020 |
Why?
| | Alkylating Agents | 1 | 2009 | 24 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 700 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2009 | 212 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 483 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1312 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1050 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2009 | 448 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1724 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1486 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4149 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5653 | 0.020 |
Why?
| | Glucose | 1 | 2011 | 1027 | 0.020 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 61 | 0.010 |
Why?
| | Rats, Zucker | 1 | 2005 | 32 | 0.010 |
Why?
| | Cell Line | 1 | 2011 | 2863 | 0.010 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 54 | 0.010 |
Why?
| | Lipid Peroxidation | 1 | 2005 | 150 | 0.010 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2005 | 97 | 0.010 |
Why?
| | Methionine | 1 | 2005 | 158 | 0.010 |
Why?
| | Malates | 1 | 2003 | 7 | 0.010 |
Why?
| | Glutathione | 1 | 2005 | 361 | 0.010 |
Why?
| | Glycolysis | 1 | 2005 | 325 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2018 | 2529 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3502 | 0.010 |
Why?
| | Risk Factors | 1 | 2017 | 10490 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2005 | 614 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2015 | 2831 | 0.010 |
Why?
| | Reperfusion Injury | 1 | 2005 | 291 | 0.010 |
Why?
| | Carbon | 1 | 2003 | 204 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2600 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2808 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2840 | 0.010 |
Why?
| | Pyruvate Carboxylase | 1 | 2000 | 3 | 0.010 |
Why?
| | Fluorescence Polarization | 1 | 2000 | 24 | 0.010 |
Why?
| | Radioisotope Dilution Technique | 1 | 2000 | 14 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1620 | 0.010 |
Why?
| | Intracellular Membranes | 1 | 2000 | 79 | 0.010 |
Why?
| | Hydrolysis | 1 | 2000 | 195 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2000 | 325 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 13727 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2000 | 834 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 1995 | 578 | 0.010 |
Why?
| | Administration, Oral | 1 | 1995 | 825 | 0.010 |
Why?
|
|
Jackman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|